CD5L is also known as apoptosis inhibitor 6 (API6) and has been reported to inhibit the activity of fatty acid synthase, in addition to inducing lipolysis during the progression of obesity [45]. Here, CD5L is linked to obesity due to melanocortin 4 receptor deficiency.